TREPROSTINIL

Drug Sandoz Inc.
Total Payments
$25,855
Transactions
880
Doctors
513
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2024 $3,638 136 117
2023 $7,584 238 178
2022 $3,665 140 113
2021 $1,699 64 57
2020 $842.03 41 38
2019 $8,050 243 153
2018 $377.12 18 18

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $23,355 878 90.3%
Space rental or facility fees (teaching hospital only) $2,500 2 9.7%

Top Doctors Receiving Payments for TREPROSTINIL — Page 21

Doctor Specialty Location Total Records
, MD Critical Care Medicine Richmond, VA $12.24 1
, M.D Pulmonary Disease Richmond, VA $12.24 1
, M.D Critical Care Medicine Richmond, VA $12.24 1
Megan Zolty Family Richmond, VA $12.24 1
, M.D Pulmonary Disease Richmond, VA $12.24 1
, M.D Critical Care Medicine Mobile, AL $12.02 1
, MD Internal Medicine Falls Church, VA $11.95 1
, M.D Internal Medicine Falls Church, VA $11.95 1
, MD Internal Medicine Falls Church, VA $11.95 1
, M.D Critical Care Medicine Falls Church, VA $11.95 1
, M.D Advanced Heart Failure and Transplant Cardiology Houston, TX $11.23 1
, MD Internal Medicine Chicago, IL $11.17 1
, M.D Internal Medicine Houston, TX $10.94 1
, MD Critical Care Medicine Falls Church, VA $10.64 1

About TREPROSTINIL

TREPROSTINIL is a drug associated with $25,855 in payments to 513 healthcare providers, recorded across 880 transactions in the CMS Open Payments database. The primary manufacturer is Sandoz Inc..

Payment data is available from 2018 to 2024. In 2024, $3,638 was paid across 136 transactions to 117 doctors.

The most common payment nature for TREPROSTINIL is "Food and Beverage" ($23,355, 90.3% of total).